AbbVie Inc., ImmunoGen File Complaint Seeking Import Ban on Antibody Drug Conjugates
November 21, 2025
November 21, 2025
WASHINGTON, Nov. 21 (TNSFR) -- AbbVie Inc., North Chicago, Illinois, ImmunoGen Inc., Waltham, Massachusetts, and ImmunoGen Switzerland GmbH, Cham, filed a complaint with the International Trade Commission alleging violations of section 337 of the Tariff Act of 1930.
The filing centers on the importation into the U.S., the sale for importation, and the domestic sale after importation of "Certain Antibody Drug Conjugates and Components Thereof and Products Containing the Same.&qu . . .
The filing centers on the importation into the U.S., the sale for importation, and the domestic sale after importation of "Certain Antibody Drug Conjugates and Components Thereof and Products Containing the Same.&qu . . .
